MTWM
CSBR icon

Masso Torrence Wealth Management’s Champions Oncology CSBR Stock Holding History

Masso Torrence Wealth Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$8K – 134
2021
Q4 		$8K Buy
+1,000
New +$9.21K 0.01% 277

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Masso Torrence Wealth Management's CSBR Position: Q1 2022 in Review

Masso Torrence Wealth Management sold out of Champions Oncology (CSBR) in Q1 2022, closing a stake of 1,000 shares — an estimated $8K sold.

Masso Torrence Wealth Management first reported a position in CSBR in Q4 2021 and held it in 1 quarter. The position peaked at $8K in Q4 2021. 30 funds tracked by Wall St. Rank hold CSBR as of Q1 2022.

  • Masso Torrence Wealth Management reported no remaining Champions Oncology position as of Q1 2022 after selling out during the quarter.
  • Masso Torrence Wealth Management sold 1,000 Champions Oncology shares in Q1 2022, an estimated $8K.
  • Masso Torrence Wealth Management first reported a position in Champions Oncology in Q4 2021 and held it in 1 quarter.
  • Masso Torrence Wealth Management's Champions Oncology position peaked at $8K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2022.

Based on Masso Torrence Wealth Management's 13F filing for Q1 2022, filed 26 Apr 2022.